Travere Therapeutics to Report Fourth Quarter and Full Year

Travere Therapeutics to Report Fourth Quarter and Full Year

SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2022......

menu
menu